In this report, Asia-Pacific Sports Medicine market is projected to reach USD 5,884.9 million by 2024 from USD 2,312.8 million in 2016, at a CAGR of 12.3% in the forecast period 2017 to 2024.

Rising incidence of sport related injuries are driving the market growth. Awareness among athletes to maintain their fitness levels has been a factor in promoting the growth of the sport medicine market in Asia Pacific. These factors increase the demand for devices such as bone graft substitutes, surgical devices, and arthroscopy devices.
The sports medicine market in the Asia-Pacific region is leading in China, India, Japan, and South Korea.
Based on geography, the Asia-Pacific Sports Medicine market is segmented into 11 geographical regions, such as,

Japan,
China,
South Korea,
India,
Australia,
Singapore,
Thailand,
Malaysia,
Indonesia,
Philippines and
Rest of Asia-Pacific.

Asia-Pacific Sports Medicine market competition by top players including -
Arthrex, Inc. is going to dominate the Asia-Pacific sports medicine market following with Smith & Nephew and DePuy Synthes, along with others such as
Stryker Corporation,
CONMED Corporation,
Johnson & Johnson,
Bird & Cronin, Inc.,
Zimmer Biomet,
Anika Therapeutics,
Ossur, Breg Inc.,
Mueller Sports Medicine, Inc.,
DJO global,
Medtronic.

The Asia-Pacific sports medicine market is segmented on the basis of product type, body area, procedures, end user, and geography.
On the basis of product type, the Asia-Pacific sports medicine market is segmented into 4 types, such as arthroscopy devices, orthobiologics, surgical devices, orthopedic braces and supports. In 2017, surgical devices market segment is projected to account for the largest share of 47.9% of the Asia-Pacific sports medicine market.
On the basis of body area, Asia-Pacific sports medicine market is segmented into hip, shoulder & elbow, knee, foot & ankle and wrist & hand on the basis of body area.

On the basis of procedures, Asia-Pacific sports medicine market is segmented into, hip arthroscopic procedures, knee arthroscopic procedures, shoulder and elbow arthroscopic procedures, , and hand and wrist arthroscopic procedures. foot and ankle arthroscopic procedures. Knee arthroscopic procedure market segment is expected to account for the largest share of 40.6% in Asia-Pacific sports medicine market.

On the basis of end users, the market is classified into, hospitals, orthopedic clinics, ambulatory surgical centers and others. In 2017, the hospitals segment is expected to dominate the Asia-Pacific sports medicine market with 56.0% market share. This segment is expected to grow at the highest CAGR of 13.7% in the forecast period 2017 to 2024.